Fast Five Quiz: Stage III Non–Small Cell Lung Cancer (NSCLC)

Maurie Markman, MD


August 30, 2022

Lung cancer is the leading cause of cancer deaths worldwide, and metastatic non–small cell lung cancer (NSCLC) is the most lethal form. Further, 5-year survival rates depend on stage and severity of disease. Most patients with NSCLC present with advanced disease; many other patients with early-stage or locally advanced disease relapse into the metastatic setting as well. Furthermore, about one third of patients present with symptoms as a result of distant metastases.

Stage III NSCLC has three main stages: stage IIIA, IIIB, or IIIC. The stage is based on the size of the tumor and the location of the lymph nodes to which the cancer has spread. Diagnostic tests are used to stage the disease and help to determine appropriate treatment and prognosis. While survival rates vary, stage III lung cancer is treatable.

How much do you know about stage III NSCLC? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.